abstract |
The invention discloses a Icotinib hydrochloride crystal form pharmaceutical composition and purpose, which relates a preparation method of 4-[(3-acetenyl-phenyl)amino]-quinazoline and [6,7-b]-12-crown-4 hydrochloride, and a related intermediate compound. |